ArticleImmunology2013

The combination of IκB kinase β inhibitor and everolimus modulates expression of interleukin-10 in human T-cell lymphotropic virus type-1-infected T cells.

Chie Nishioka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.